⚖️DEA Decision on Svetlana Burtman
Svetlana Burtman, N.P.; Decision and Order
Summary
The Department of Justice's ruling on Svetlana Burtman highlights numerous violations of the Controlled Substances Act, including operating an unregistered practice and failing to maintain adequate records. This decision underscores the rigorous compliance requirements for healthcare providers regarding controlled substances. The ramifications may extend beyond individual practitioners, influencing broader regulatory practices in the healthcare industry.
Agencies
- Justice Department
- Drug Enforcement Administration
Business Impact
$$$ - High
The content details regulatory violations by a healthcare provider related to the dispensing of controlled substances without proper registration, which poses direct compliance risks for businesses in the healthcare sector. Non-compliance can lead to revocation of licenses and lead to financial losses.